未接受α干扰素或伊马替尼治疗的慢性期慢性髓性白血病患者的正常固有Th1/Th2平衡
Normal intrinsic Th1/Th2 balance in patients with chronic phase chronic myeloid leukemia not treated with interferon-alpha or imatinib.
作者信息
Kiani Alexander, Habermann Ivonne, Schäke Knut, Neubauer Andreas, Rogge Lars, Ehninger Gerhard
机构信息
Dept. of Medicine, University Hospital Carl Gustav Carus, Technical University Dresden, Dresden, Germany.
出版信息
Haematologica. 2003 Jul;88(7):754-61.
BACKGROUND AND OBJECTIVES
CD4+ T helper cells are an integral part of effective immune responses against various malignancies; however in tumor-bearing patients they are frequently functionally unresponsive. T helper cells of patients with chronic myeloid leukemia (CML), analyzed as part of mononuclear cell fractions, show a loss of signaling molecules, a compromised Th1 cytokine production and a shift towards a non-productive Th2 state. The underlying mechanism is unknown and may involve intrinsic T cell defects as well as indirect effects mediated by leukemia or antigen-presenting cells. The purpose of the present study was to analyze the intrinsic cytokine-producing capacity of purified CML T helper cells in the absence of other cell types.
DESIGN AND METHODS
Untouched CD4+ T cells with a purity of more than 90% were isolated from 10 patients with Ph+ chronic phase CML on maintenance treatment with hydroxyurea. The cells were isolated by density gradient centrifugation followed by immunomagnetic depletion of leukemia and accessory cells. The ex vivo cytokine-producing capacity of CML T helper cells in response to polyclonal stimulation with anti-CD3 and anti-CD28 was then compared to that of cells purified from matched healthy volunteers.
RESULTS
T helper cells purified from CML patients produced comparable amounts of the Th1 cytokines interleukin (IL)-2 and interferon (IFN)-g as cells purified from healthy volunteers. Likewise, no difference between CML and control T helper cells was found with respect to the Th2 cytokines, IL-4 and IL-13, as well as the immunomodulatory cytokine, IL-10.
INTERPRETATION AND CONCLUSIONS
In the absence of leukemia and accessory cells, the intrinsic cytokine-producing capacity of CML T helper cells is normal. A Th2 shift was not detected, and the predominant presence of an IL-10-producing, immunosuppressive T helper cell subset could be excluded.
背景与目的
CD4 + T辅助细胞是针对各种恶性肿瘤的有效免疫反应的重要组成部分;然而,在荷瘤患者中,它们常常功能无反应。作为单核细胞组分进行分析的慢性髓性白血病(CML)患者的T辅助细胞显示信号分子缺失、Th1细胞因子产生受损以及向无活性的Th2状态转变。其潜在机制尚不清楚,可能涉及T细胞内在缺陷以及白血病或抗原呈递细胞介导的间接效应。本研究的目的是在不存在其他细胞类型的情况下分析纯化的CML T辅助细胞产生细胞因子的内在能力。
设计与方法
从10例接受羟基脲维持治疗的Ph + 慢性期CML患者中分离出纯度超过90%的未受干扰的CD4 + T细胞。通过密度梯度离心,随后对白血病细胞和辅助细胞进行免疫磁珠去除来分离细胞。然后将CML T辅助细胞在抗CD3和抗CD28多克隆刺激下体外产生细胞因子的能力与从匹配的健康志愿者中纯化的细胞进行比较。
结果
从CML患者中纯化的T辅助细胞产生的Th1细胞因子白细胞介素(IL)-2和干扰素(IFN)-γ的量与从健康志愿者中纯化的细胞相当。同样,在Th2细胞因子IL-4和IL-13以及免疫调节细胞因子IL-10方面,未发现CML和对照T辅助细胞之间存在差异。
解读与结论
在不存在白血病细胞和辅助细胞的情况下,CML T辅助细胞产生细胞因子的内在能力是正常的。未检测到Th2偏移,并且可以排除产生IL-10的免疫抑制性T辅助细胞亚群的主要存在。